Sai Life Sciences, a contract research, development, and manufacturing organization (CRDMO) focused on innovative medicines, announced Unit VI inauguration in Bidar, India, to manufacture veterinary active pharmaceutical...
Biocon Biologics Ltd. has received FDA approval for its denosumab biosimilars, Bosaya and Aukelso, marking a major milestone in expanding affordable biologic therapies in the U.S.
AstraZeneca has announced today landmark data from the Phase III FLAURA2 trial, demonstrating that its targeted therapy, Tagrisso (osimertinib), plus pemetrexed and platinum-based chemotherapy, achieved the longest overall survival reported in any...
AstraZeneca has received a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) for a protocol being amended to widen the ongoing global clinical trial
Merck (known as MSD outside of the US and Canada) presented positive Phase 3 trial results for Capvaxive for kids at the 6th ESCMID Conference on Vaccines in Lisbon, Portugal. The STRIDE-13 study assessed the vaccine in children and adolescents...
The World Health Organization (WHO) has announced the establishment of a Guideline Development Group (GDG) to develop the first evidence-based recommendations on multiplex testing for HIV, viral hepatitis, and sexually transmitted infections (STIs)..
Hyderabad-based Dr Reddy's Laboratories said on Tuesday that it has finalized a definitive transaction the Stugeron brand from Johnson & Johnson across the EMEA countries, describing India and Vietnam as important growth markets for Stugeron...
Pfizer Inc. and BioNTech SE announced promising topline findings from a phase 3 study of their LP.8.1-adapted Comirnaty Covid-19 vaccine (2025-2026 Formula) that targets the SARS-CoV-2 evolution. The study involved adults aged 65 and older and...
Mankind Pharma, India's fourth largest pharma company, has received approval from CDSCO to conduct a phase 1 clinical trial for its new JAK-1 inhibitor, MKP11093. The orally available drug molecule, which has been developed at Mankind Research...
.jpeg)
Glenmark Pharmaceuticals has also begun a global Phase 3 clinical trial with Envafolimab, a new medication to treat patients with third stage non-small cell lung cancer (NSCLC). The shift highlights the increasing role of India in late-stage drug dev
.jpg)
, CDSCO.jpg)